Research indicates that 90% of osteogenesis imperfecta (OI) cases result from pathogenic variants in the COL1A1 or COL1A2 genes, which encode the α1 and α2 chains of type I collagen, respectively. This evidence concerns the gene COL1A1 and osteogenesis imperfecta.